| Standardization of laboratory and lipid profile evaluation: A call for action with a special focus in 2016 ESC/EAS dyslipidaemia guidelines - Full report |
6 |
| The role of red yeast rice (RYR) supplementation in plasma cholesterol control: A review and expert opinion |
6 |
| Notch, BMP and WNT/beta-catenin network is impaired in endothelial cells of the patients with thoracic aortic aneurysm |
4 |
| Statin-induced muscular side effects at rest and exercise - An anatomical mapping |
3 |
| Experience with proprotein convertase subtilisin/kexine type 9 inhibitors (PCSK9i) in patients undergoing lipoprotein apheresis |
3 |
| Lipoprotein(a) - Marker for cardiovascular risk and target for lipoprotein apheresis |
2 |
| Optical coherence tomography of retinal and choroidal layers in patients with familial hypercholesterolaemia treated with lipoprotein apheresis |
2 |
| Immunoadsorption in nephrotic syndrome: Where are we now and where are we going from here? |
2 |
| ADMA elevation does not exacerbate development of diabetic nephropathy in mice with streptozotocin-induced diabetes mellitus |
2 |
| Effectiveness of different immunoadsorption columns for anti-A/B antibody depletion |
2 |
| Kidney and liver are the main organs of expression of a key metabolic enzyme alanine:glyoxylate aminotransferase 2 in humans |
2 |
| Epidemiology of cardiovascular risk factors in two population-based studies |
2 |
| Familial hypercholesterolemia in China half a century: A review of published literature |
2 |
| Investigating the association between familial hypercholesterolemia and perceived depression |
2 |
| Percutaneous coronary intervention for a Chinese familial hypercholesterolemia homozygous under the guidance of optical coherence tomography |
1 |
| Variable expression and penetrance in Portuguese families with Familial Hypercholesterolemia with mild phenotype |
1 |
| Achilles tendon ultrasonography - A useful screening tool for cardiovascular risk estimation in patients with severe hypercholesterolemia |
1 |
| Actual situation of lipoprotein apheresis in patients with elevated lipoprotein(a) levels |
1 |
| Lipoprotein apheresis in Germany - Still more commonly indicated than implemented. How can patients in need access therapy? |
1 |
| Efficiency and problems of statin therapy in patients with heterozygous familial hypercholesterolemia |
1 |
| Homozygous familial hypercholesterolaemia in childhood - The first case report in Southeast Europe |
0 |
| A successful term pregnancy with severe hypertriglyceridaemia and acute pancreatitis. Clinical management and review of the literature |
0 |
| Lipoprotein apheresis - Shortening of treatment intervals reduces cardiovascular events: Case reports |
0 |
| Large artery stiffness according to different assessment methods in adult population of St. Petersburg |
0 |
| A complicated pregnancy in homozygous familial hypercholesterolaemia treated with lipoprotein apheresis: A case report |
0 |
| Cardiovascular risk factors in patients with premature cardiovascular events attending the University of Dresden Lipid Clinic |
0 |
| Serum uric acid and left ventricular geometry pattern in obese children |
0 |
| Apheresis as emerging treatment option in severe early onset preeclampsia |
0 |
| One year follow-up of patients with reduced left ventricular ejection fraction (LVEF) on lipoprotein apheresis |
0 |
| Short- and long-term effects of lipoprotein apheresis on plasma hormones in patients with therapy-resistant dyslipidemia |
0 |
| Influence of lipoprotein apheresis on circulating plasma levels of miRNAs in patients with high Lp(a) |
0 |
| Lipoprotein apheresis in Austria - Reduction of cardiovascular events by regular lipoprotein apheresis treatment |
0 |
| Establishing a familial hypercholesterolaemia register - The first year |
0 |
| The frequency of familial hypercholesterolemia amongst patients in the outpatient clinic of the tertiary specialized cardiology center in Kyrgyzstan |
0 |
